Project Grant R01AA032262
- Summary of Federal Project Grant Award The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded $733,704 to Lovelace Biomedical Research Institute on September 1, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct a multimodal neuroimaging study examining the neural mechanisms underlying spatial memory deficits in children and adolescents exposed to prenatal alcohol exposure (PAE). The research employs functional magnetic resonance imaging (fMRI) and...
- Federal Grant Award Summary The Ohio State University received a $593,803 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), effective September 20, 2025, through June 30, 2030. This research project will conduct mechanistic characterization of JNK2A (c-Jun N-terminal kinase 2A) variants to elucidate the biological pathways underlying alcohol-caused heart failure (ACM). The research will produce fundamental...
- Federal Project Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded The Medical University of South Carolina $459,707 on September 5, 2025, under the Alcohol Research Programs (CFDA 93.273) to support a five-year research project extending through May 31, 2030. This Project Grant funds basic neuroscience research investigating the physiological mechanisms underlying alcohol use disorder (AUD), specifically examining how chronic intermittent ethanol (CIE)...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded the University of Maryland, Baltimore a Project Grant totaling $1.74M under the Alcohol Research Programs (CFDA 93.273) to conduct basic neuroscience research examining the effects of developmental alcohol exposure on sensory cortical processing. The award, dated September 26, 2025, with a completion date of May 31, 2030, funds research investigating how fetal alcohol spectrum disorders (FASD)...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded the University of Florida a $560,108 Project Grant on September 15, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct a five-year investigation into the neurocognitive mechanisms of resilience to alcohol use disorder (AUD). The research will examine how attentional ability protects against AUD development in at-risk young adults with a family history of alcohol use disorder. This...
- Federal Grant Award Summary The University of New Mexico Health Sciences Center received a $160,744 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), effective March 9, 2026, with completion targeted for December 31, 2030. This research initiative will deliver scientific investigation into the electrophysiological mechanisms underlying cognitive control deficits associated with prenatal alcohol exposure (PAE). The...
- Federal Project Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded The Ohio State University a $692,723 Project Grant on September 18, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct clinical research on orexin receptor antagonism for treating alcohol use disorder (AUD) and stress-related drinking. The award funds a double-blind, placebo-controlled randomized controlled trial (RCT) with 250 treatment-seeking individuals with current AUD,...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $459,343 Project Grant to the University of Pittsburgh under the Alcohol Research Programs (CFDA 93.273) to conduct fundamental neuroscience research examining the mechanisms through which alcohol affects prefrontal cortex circuits, with performance extending from September 20, 2025 through July 31, 2030. The research focuses on understanding how vasoactive intestinal peptide-expressing...
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $283,376 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) on May 15, 2026, with a completion date of April 30, 2028. This Phase 1 clinical trial will deliver research services investigating the efficacy of sensory-enriched occupational therapy intervention for children aged 6-8 years with Fetal Alcohol...
- Federal Project Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded $188,313 to the University of Tennessee Health Science Center (UTHSC) on September 26, 2025, under the Alcohol Research Programs (CFDA 93.273) to support research evaluating the synergistic effects of developmental and adult alcohol exposure on Alzheimer's disease (AD)-related phenotypes. The research project, with a completion date of August 31, 2027, investigates how ethanol exposure...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded The Ohio State University $474,223 on May 11, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct research on the mechanisms and neuroprotective targets in alcohol-induced brain injury. This project, scheduled for completion by January 31, 2031, aims to elucidate the brain region- and cell-specific mechanisms underlying alcohol-induced developmental neurotoxicity (AIDN) and develop precision interventions to address Fetal Alcohol Spectrum Disorders (FASD), which represent a major public health concern affecting 1–5% of the U.S. population with an estimated annual economic burden of $5 billion. The research delivers comprehensive mechanistic understanding through multidisciplinary scientific approaches, including virus-based cell-specific gene modification, spatial transcriptomics, multiphoton imaging, and behavioral assessments. The study utilizes complementary research models—human induced pluripotent stem cell-derived 3D mini brains and mouse models—to investigate AIDN mechanisms at molecular, cellular, tissue, and animal levels. The project's primary deliverables include identification of neuron-specific signaling pathways contributing to alcohol vulnerability, characterization of brain region- and cell-specific neuroprotection targets, and evaluation of neuron-specific and mitochondria-targeted interventions, collectively advancing the scientific knowledge base for improved treatment and prevention strategies for alcohol-related developmental neurotoxicity.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $474.2k | 5/14/26 |